SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001214659-23-005941
Filing Date
2023-04-25
Accepted
2023-04-25 16:05:23
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 hgen-20221231.htm   iXBRL 10-K/A 330913
2 EXHIBIT 10.21 ex10_21.htm EX-10.21 105906
3 EXHIBIT 31.3 ex31_3.htm EX-31.3 3109
4 EXHIBIT 31.4 ex31_4.htm EX-31.4 2984
  Complete submission text file 0001214659-23-005941.txt   738371

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hgen-20221231.xsd EX-101.SCH 3196
6 XBRL DEFINITION FILE hgen-20221231_def.xml EX-101.DEF 16499
7 XBRL LABEL FILE hgen-20221231_lab.xml EX-101.LAB 33841
8 XBRL PRESENTATION FILE hgen-20221231_pre.xml EX-101.PRE 17517
10 EXTRACTED XBRL INSTANCE DOCUMENT hgen-20221231_htm.xml XML 9180
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35798 | Film No.: 23844858
SIC: 2834 Pharmaceutical Preparations